Importantly, MCL-1 was required for breast cancer stem cell function in vitro and this was also due to MCL-1’s canonical anti-apoptotic function since it could be ablated by deletion of BAX/BAK and targeted with MCL-1-specific BH3-mimetic drugs. Here, BAX is linked to breast cancer.